ETNB Chart
- 52-Week Range: $2.09 - $21.77
- Market Capitalization: $60.24M
- Short Percentage: 0%
- Target Price: $27.44
- Shares Outstanding: 20.35M
- Next Earnings: Nov 30
Catalysts
CategoryCatalyst
Earnings
ETNB released their earnings report for the previous quarter and provided guidance on the current and upcoming quarters.
News and Press Releases
- 89bio Reports First Quarter 2022 Financial Results and Provides Corporate UpdateGlobeNewsWire | May 11th
- 89bio Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate UpdateGlobeNewsWire | March 24th
- 89bio to Participate in the SVB Leerink 11ᵗʰ Annual Global Healthcare ConferenceGlobeNewsWire | February 9th
- 89bio Presents New Data from Phase 1b/2a NASH Study Showing BIO89-100 Reduces Spleen VolumeGlobeNewsWire | November 14th
- 89bio Reports Third Quarter 2021 Financial Results and Provides Corporate UpdateGlobeNewsWire | November 11th
- 89bio Announces Appointment of Kathy LaPorte to its Board of DirectorsGlobeNewsWire | November 3rd
- 89bio to Present New Sub-Analysis from Phase 1b/2a NASH Study of BIO89-100 at AASLD's The Liver Meeting 2021GlobeNewsWire | October 25th
- 89bio to Participate in the H.C. Wainwright 23rd Annual Global Investment ConferenceGlobeNewsWire | September 8th
Company Info
Website: https://www.89bio.com
Address: 142 Sansome Street, San Francisco, CA, United States, 94104
Sector: Healthcare
Industry: Biotechnology
Full time employees: 41
Address: 142 Sansome Street, San Francisco, CA, United States, 94104
Sector: Healthcare
Industry: Biotechnology
Full time employees: 41
$ETNB buy
$ETNB Tendie tickets on discount today!!!
$ETNB i'm out of slaps for the day
$ETNB you wanna be a successful trader close your trades green
$ETNB News Plz.....
$ETNB Bull trap
$ETNB bull trap confirmed
$ETNB make it rain
let’s see some green
$ETNB Slapping that ask today